Angiogenesis, Exudation, and Degeneration 2025


Angiogenesis, Exudation, and Degeneration 2025 Banner

Add to Calendar Angiogenesis, Exudation, and Degeneration 2025 2/8/2025 8:00:00 AM 2/8/2025 7:00:00 PM America/New_York For More Details: https://miami.cloud-cme.com/course/courseoverview?EID=16686 Description: Angiogenesis 2025 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2024. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will em... Online false MM/DD/YYYY


Date & Location
Saturday, February 8, 2025, 8:00 AM - 7:00 PM, Online

Target Audience
Specialties - Ophthalmology
Professions - Fellow, Ophthalmologist, Physician, Researcher, Resident, Scientist

Credits
AMA PRA Category 1 Credits™ (11.00 hours), Non-Physician Attendance (11.00 hours)

Overview
Angiogenesis 2025 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2024. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will emphasize investigator-initiated research and recently completed clinical trials focused on the diagnosis and treatment of a wide range of retinal diseases with special emphasis on age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases.

Objectives
At the conclusion of this activity, learners will be able to:

  1. • Examine new evidence for understanding the pathophysiology in nonexudative age-related macular degeneration
  2. • Examine new evidence for predicting disease progression in nonexudative age-related macular degeneration
  3. • Incorporate the latest advances in artificial intelligence, specifically machine learning, for the diagnosis and treatment of retinal diseases
  4. • Evaluate emerging therapies for the treatment of nonexudative age-related macular degeneration and review the real-world outcomes following the use of complement inhibitors in clinical practice to better understand the population most likely to benefit from these drugs
  5. • Evaluate therapies targeting novel disease pathways being investigated in early-stage clinical trials for nonexudative age-related macular degeneration
  6. • Provide an update on the next generation of anti-VEGF therapies recently approved and currently in development
  7. • Evaluate the clinical use of available anti-VEGF drugs for exudative ocular diseases
  8. • Evaluate emerging therapies for the treatment of exudative age-related macular degeneration and understand how we might use these new therapies in conjunction with established anti-VEGF drugs and better understand the population most likely to benefit from these new drugs.

Registration

Register here.

 


Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 11.00 of AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME


Additional Information

Cancellation Policy

For more information, email [email protected].

Accessibility Statement
 
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.



Keywords: LIVE